Company / SG&A Expense
AVITA Medical, Inc. SG&A Expense History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$33.2M
FY2025
5-year range
$15.1M / $33.2M
FY2021-FY2025
Trend
+17.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 5 consecutive years, from $9M in FY2020 to $33M in FY2025.
Based on SEC 10-K filings.
$33M in FY2025 with a 5-year CAGR of +28.7%.
Increased from $23M to $33M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +14.0%
- 5-Year CAGR
- +28.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- AVITA Medical, Inc.'s sg&a expense has grown for 5 consecutive years.
- 5-year CAGR of +28.7%, indicating consistent growth.
- In FY2025, sg&a expense increased 17.2% year-over-year.
- Lowest sg&a expense in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -2.29 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $33.2M | +17.2% |
| FY2024 | $28.3M | +21.4% |
| FY2023 | $23.3M | +4.2% |
| FY2022 | $22.4M | +48.4% |
| FY2021 | $15.1M | +60.6% |
| FY2020 | $9.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026